Skip to main content

Marianne Kirby Rhodes

11/26/2014
The specialist healthcare company BTG has announced that its DC Bead and Bead Block products will be sold directly to customers in 11 European countries beginning April 1, 2015. The complementary interventional drug-eluting and embolization...
The specialist healthcare company BTG has announced that its DC Bead and Bead Block products will be sold directly to customers in 11 European countries beginning April 1, 2015. The complementary interventional drug-eluting and embolization...
The specialist healthcare...
11/26/2014
IO Learning
Clinical Insights
08/05/2015
The landmark SIRFLOX trial, a randomized controlled trial of SIR-Spheres Y90 microspheres (Sirtex) in patients with metastatic colorectal cancer (mCRC), has shown evidence suggesting that a first-line treatment strategy of standard of care...
The landmark SIRFLOX trial, a randomized controlled trial of SIR-Spheres Y90 microspheres (Sirtex) in patients with metastatic colorectal cancer (mCRC), has shown evidence suggesting that a first-line treatment strategy of standard of care...
The landmark SIRFLOX trial, a...
08/05/2015
IO Learning
Clinical Insights
01/27/2015
An uptick in the use of interventional oncology is spurring creation of programs and opportunities for physicians and medical students who want to explore these new, minimally invasive therapies in a structured educational setting....
An uptick in the use of interventional oncology is spurring creation of programs and opportunities for physicians and medical students who want to explore these new, minimally invasive therapies in a structured educational setting....
An uptick in the use of...
01/27/2015
IO Learning